Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Boisvert

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Science (New York, N.Y.)|September 13, 2003
Transcriptional repression of atherogenic inflammation: modulation by PPARdeltaChih-Hao Lee, Ajay Chawla, Ned Urbiztondo, et al.
The American Journal of Clinical Nutrition|July 1, 1993
Prevalence of riboflavin deficiency among Guatemalan elderly people and its relationship to milk intakeW A Boisvert, C Castañeda, I Mendoza, et al.
The Journal of Nutrition|May 1, 1993
Riboflavin requirement of healthy elderly humans and its relationship to macronutrient composition of the dietW A Boisvert, I Mendoza, C Castañeda, et al.
Metabolites|January 21, 2023
Alterations in Renin-Angiotensin System (RAS) Peptide Levels in Patients with HIVIsaac Asante, Angela Lu, Brooks I Mitchell, et al.
Conditioning Medicine|July 16, 2021
Nanoparticle delivery of cardioprotective therapiesAbraham Mendez-Fernandez, Hector A Cabrera-Fuentes, Bhaarathy Velmurugan, et al.
The American Journal of Pathology|December 6, 2008
Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in miceJonathan M Gitlin, Jonathon W Homeister, Joshua Bulgrien, et al.
Nature Communications|October 26, 2017
Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesisYvonne Baumer, Sara McCurdy, Tina M Weatherby, et al.
Discoveries (Craiova, Romania)|April 19, 2016
Validation of commercially available ELISAs for the detection of circulating sclerostin in hemodialysis patientsSebastian F Mause, Annika Deck, Mark Hennies, et al.
Conditioning Medicine|May 28, 2020
INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHYChrishan J A Ramachandra, K P Myu Mai Ja, Ying-Hsi Lin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Leukocyte transglutaminase 2 expression limits atherosclerotic lesion sizeW A Boisvert, D M Rose, A Boullier, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Science (New York, N.Y.)|September 13, 2003
Transcriptional repression of atherogenic inflammation: modulation by PPARdeltaChih-Hao Lee, Ajay Chawla, Ned Urbiztondo, et al.
The American Journal of Clinical Nutrition|July 1, 1993
Prevalence of riboflavin deficiency among Guatemalan elderly people and its relationship to milk intakeW A Boisvert, C Castañeda, I Mendoza, et al.
The Journal of Nutrition|May 1, 1993
Riboflavin requirement of healthy elderly humans and its relationship to macronutrient composition of the dietW A Boisvert, I Mendoza, C Castañeda, et al.
Metabolites|January 21, 2023
Alterations in Renin-Angiotensin System (RAS) Peptide Levels in Patients with HIVIsaac Asante, Angela Lu, Brooks I Mitchell, et al.
Conditioning Medicine|July 16, 2021
Nanoparticle delivery of cardioprotective therapiesAbraham Mendez-Fernandez, Hector A Cabrera-Fuentes, Bhaarathy Velmurugan, et al.
The American Journal of Pathology|December 6, 2008
Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in miceJonathan M Gitlin, Jonathon W Homeister, Joshua Bulgrien, et al.
Nature Communications|October 26, 2017
Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesisYvonne Baumer, Sara McCurdy, Tina M Weatherby, et al.
Discoveries (Craiova, Romania)|April 19, 2016
Validation of commercially available ELISAs for the detection of circulating sclerostin in hemodialysis patientsSebastian F Mause, Annika Deck, Mark Hennies, et al.
Conditioning Medicine|May 28, 2020
INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHYChrishan J A Ramachandra, K P Myu Mai Ja, Ying-Hsi Lin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Leukocyte transglutaminase 2 expression limits atherosclerotic lesion sizeW A Boisvert, D M Rose, A Boullier, et al.
Pageof 12